-
公开(公告)号:US20240299321A1
公开(公告)日:2024-09-12
申请号:US18258673
申请日:2021-12-10
发明人: Xiongbin LU , Xinna ZHANG
IPC分类号: A61K31/167 , A61K31/4468 , A61K31/517 , A61K45/06 , A61P35/00 , G01N33/50
CPC分类号: A61K31/167 , A61K31/4468 , A61K31/517 , A61K45/06 , A61P35/00 , G01N33/505 , G01N33/5088 , G01N2500/10
摘要: This invention is directed to pharmaceutical compositions and methods for increasing immunogenicity in a cancer cell by contacting a cancer cell with epigenetic inhibitors to prompt the cancer cell's production of MHC-I-associated tumor antigens.
-
公开(公告)号:US20230404967A1
公开(公告)日:2023-12-21
申请号:US18035694
申请日:2021-11-30
发明人: Xiongbin LU , Xinna ZHANG , Kevin VAN DER JEUGHT
IPC分类号: A61K31/365 , A61K45/06 , A61P35/00
CPC分类号: A61K31/365 , A61K45/06 , A61P35/00
摘要: The present disclosure relates to compositions and methods to induce or increase immunogenicity in cancerous cells comprising contacting the cancerous cells with atractylenolide I (ATT-I). In some embodiments, the methods include contacting the cancerous cells with ATT-I in combination with a cancer therapeutic agent.
-